Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis

Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma with early metastatic potential. The standard-of-care treatment has not changed in years. Recent studies report improved progression-free survival (PFS) and overall survival (OS) with combined ICI and chemotherapy in ES-SCLC. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathiyapalan, Arani, Febbraro, Michela, Pond, Gregory R., Ellis, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776593/
https://www.ncbi.nlm.nih.gov/pubmed/36547123
http://dx.doi.org/10.3390/curroncol29120709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776593/
https://www.ncbi.nlm.nih.gov/pubmed/36547123
http://dx.doi.org/10.3390/curroncol29120709

Ejemplares similares